José Juan
García Marín
Catedrático de Universidad
Publicaciones (305) Publicaciones de José Juan García Marín
2024
-
Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
Biochemical Pharmacology
-
Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2
-
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
Biomedicine and Pharmacotherapy, Vol. 170
-
Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells
Biomedicine and Pharmacotherapy, Vol. 174
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs
Biomedicine and Pharmacotherapy, Vol. 168
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
-
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
Cells, Vol. 12, Núm. 8
-
Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells
Biomedicine and Pharmacotherapy, Vol. 165
-
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma
Biochemical Pharmacology, Vol. 214
-
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers, Vol. 15, Núm. 12
-
Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors
Biochemical Pharmacology, Vol. 217
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
-
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma
International Journal of Molecular Sciences, Vol. 24, Núm. 3
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
-
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
Cancers, Vol. 14, Núm. 14
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24
-
Impact of alternative splicing variants on liver cancer biology
Cancers, Vol. 14, Núm. 1
-
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
Seminars in Liver Disease, Vol. 42, Núm. 1, pp. 087-103